Sensei Biotherapeutics CEO John Celebi's 2022 pay falls 77% to $1.6M
Sensei Biotherapeutics reports 2022 executive compensation
By ExecPay News
Published: June 15, 2023
Sensei Biotherapeutics reported fiscal year 2022 executive compensation information on June 15, 2023.
In 2022, four executives at Sensei Biotherapeutics received on average a compensation package of $1.1M, a 69% decrease compared to previous year.
Average pay of disclosed executives at Sensei Biotherapeutics
John Celebi, Chief Executive Officer, received $1.6M in total, which decreased by 77% compared to 2021. 34% of Celebi's compensation, or $537K, was in option awards. Celebi also received $228K in non-equity incentive plan, $513K in salary, $232K in stock awards, as well as $59K in other compensation.
Robert Pierce, Former Chief R&D Officer, received a compensation package of $1.2M, which decreased by 47% compared to previous year. 35% of the compensation package, or $421K, was in salary.
Erin Colgan, Chief Financial Officer, earned $855K in 2022, a 30% decrease compared to previous year.
Edward van der Horst, Chief Scientific Officer, received $654K in 2022.
Related executives
You may also like
Source: SEC filing on June 15, 2023.